pyrimethamine has been researched along with Cognitive Dysfunction in 1 studies
Maloprim: contains above 2 cpds
Cognitive Dysfunction: Diminished or impaired mental and/or intellectual function.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marzolini, MAV | 1 |
| Jaunmuktane, Z | 1 |
| Roddie, C | 1 |
| O'Reilly, M | 1 |
| Chiodini, P | 1 |
| Peggs, KS | 1 |
1 other study available for pyrimethamine and Cognitive Dysfunction
| Article | Year |
|---|---|
Toxoplasmosis initially presenting as neurological sequelae of chimeric antigen receptor T-cell therapy.
Topics: Cognitive Dysfunction; Humans; Immunotherapy, Adoptive; Leukemia, Lymphocytic, Chronic, B-Cell; Male | 2019 |